POL6326 (Balixafortide) Plus Nab-paclitaxel or Eribulin in Patients With HER2-negative Advanced Breast Cancer

Clinical trial NCT04826016 · WITHDRAWN

Trial details

NCT number: NCT04826016
Sponsor: MedSIR
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2022-03-16
Primary completion: 2022-03-16
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.